Patent Portfolio
Nucleic acid medicine for hereditary motor and sensory neuropathy with proximal dominant involvement
| Ref. No. | AJ307 |
|---|---|
| Appl. No. (filing date) |
PCT/JP2026/010029(2026/3/13) |
| Pub. No. (Pub. date) |
WO2026/192068(2026/9/17) |
| Priority claim No. (Priority date) |
JP2025-041887(2025/03/14) |
| Inventor | INOUE Haruhisa, et al. |
| Assignee | Kyoto University |
| Title of Invention | Nucleic acid medicine for hereditary motor and sensory neuropathy with proximal dominant involvement |
| Abstract | The present invention relates to an antisense oligonucleotide that suppresses the expression level of the TRK-fused gene (TFG), and to its use. |
| Comments |
The antisense oligonucleotide (ASO) of the present invention can effectively reduce the expression levels of TFG—specifically, human TFG—mRNA and protein. |